Guo X, Yang W, Zhang J, Dong X, et al. iGlarLixi provides a higher derived time-in-range versus insulin glargine 100 U/mL or lixisenatide in Asian Pacific people with type 2 diabetes: A post hoc analysis. Diabetes Obes Metab 2023 Mar 30. doi: 10.1111/dom.15074.
PMID: 36999231